Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 27;195(12):E462-E463.
doi: 10.1503/cmaj.220730-f.

Injection mensuelle de buprénorphine à libération prolongée

[Article in French]
Ari B Cuperfain  1 , Tianna Costa Pharmacienne  1 , Nitin Chopra  2
Affiliations

Injection mensuelle de buprénorphine à libération prolongée

[Article in French]
Ari B Cuperfain et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents: Ari Cuperfain indique avoir reçu la bourse John Renner Award de l’American Association of Addiction Psychiatry. Aucun autre intérêt concurrent n’a été déclaré.

References

    1. Haight BR, Learned SM, Laffont CM, et al. RB-US-13-0001 2Study Investigators. Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2019;393:778–90. - PubMed
    1. Ling W, Shoptaw S, Goodman-Meza D. Depot buprenorphine injection in the management of opioid use disorder: from development to implementation. Subst Abuse Rehabil 2019; 10:69–78. - PMC - PubMed
    1. Lintzeris N, Dunlop AJ, Haber PS, et al. . Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial. JAMA Netw Open 2021; 4:e219041. - PMC - PubMed
    1. Peckham AM, Kehoe LG, Gray JR, et al. . Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: a retrospective case series. J Subst Abuse Treat 2021;126: 108316. - PubMed
    1. Lee JD, Malone M, McDonald R, et al. . Comparison of treatment retention of adults with opioid addiction managed with extended-release buprenorphine vs daily sublingual buprenorphine-naloxone at time of release from jail. JAMA Netw Open 2021;4:e2123032. - PMC - PubMed

MeSH terms